Literature DB >> 18358634

Overexpression of cyclin D1, D3, and p21 in an infantile renal carcinoma with Xp11.2 TFE3-gene fusion.

J Müller-Höcker1, G Babaryka, I Schmid, A Jung.   

Abstract

Renal carcinomas harboring the TFE-3 translocation are rare and occur predominately in children and adolescents. Here, we report a case of infantile renal carcinoma with TFE3 translocation and show that the cell cycle is deregulated in this type of carcinoma. It is characterized by nuclear accumulation of cyclin D1 and D3 in combination with high levels of cyclin-dependent kinase inhibitor p21Cip1/Waf1 but without accumulation of p53, p16INK4a, or mdm2. The combined overexpression of p21, cyclin D1, and cyclin D3 was found exclusively in this type but not in other, more common types of renal carcinoma/oncocytoma (n=27). These results further underscore that renal carcinomas with Xp11. 2 translocations/TFE3-gene fusion represent a special type of renal neoplasm showing deregulation of specific cell cycle components. The analysis of further cases has to prove whether the derangement of the cell cycle is uniform and correlates with the specific type of molecular genetic derangement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18358634     DOI: 10.1016/j.prp.2008.01.010

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  7 in total

1.  Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers.

Authors:  Pedram Argani; Jessica Hicks; Angelo M De Marzo; Roula Albadine; Peter B Illei; Marc Ladanyi; Victor E Reuter; George J Netto
Journal:  Am J Surg Pathol       Date:  2010-09       Impact factor: 6.394

Review 2.  Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.

Authors:  Eric C Kauffman; Christopher J Ricketts; Soroush Rais-Bahrami; Youfeng Yang; Maria J Merino; Donald P Bottaro; Ramaprasad Srinivasan; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2014-07-22       Impact factor: 14.432

Review 3.  Novel roles for the MiTF/TFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasis.

Authors:  José A Martina; Heba I Diab; Huiqing Li; Rosa Puertollano
Journal:  Cell Mol Life Sci       Date:  2014-01-30       Impact factor: 9.261

Review 4.  TFEB at a glance.

Authors:  Gennaro Napolitano; Andrea Ballabio
Journal:  J Cell Sci       Date:  2016-06-01       Impact factor: 5.285

5.  The relevance of testing the efficacy of anti-angiogenesis treatments on cells derived from primary tumors: a new method for the personalized treatment of renal cell carcinoma.

Authors:  Renaud Grépin; Damien Ambrosetti; Alexandre Marsaud; Lauris Gastaud; Jean Amiel; Florence Pedeutour; Gilles Pagès
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

Review 6.  Prognostic significance of cyclin D3 expression in malignancy patients: a meta-analysis.

Authors:  Bo Wang; Zijian Wang; Lizhi Han; Song Gong; Yanxue Wang; Zhiwen He; Yong Feng; Zhaohui Yang
Journal:  Cancer Cell Int       Date:  2019-06-10       Impact factor: 5.722

7.  NRF-1 directly regulates TFE3 and promotes the proliferation of renal cancer cells.

Authors:  Wenyuan Zhuang; Xiang Dong; Bo Wang; Ning Liu; Hongqian Guo; Chunni Zhang; Weidong Gan
Journal:  Oncol Lett       Date:  2021-07-22       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.